Coronary Stent Market to Reach $8.08 Billion by 2027; Increasing Product Adoption in PCI Procedures ill Aid Growth, says Fortune Business Insights™

Market Overview:

The global Coronary Stent Market size is projected to reach USD 8.08billion by the end of 2027. High investment in technological intervention has opened up a huge potential for market growth. According to a report published by Fortune Business Insights, titled “Coronary Stent Market Size, Share & Industry Analysis, By Stent Type (Drug-Eluting Stent, Bio resorbable Stent, Bare Metal Stent, Covered Stent, Others), By Deployment (Self-expandable, Balloon-expandable), By End User (Hospitals & Ambulatory Surgical Centers, Specialty Clinics, Others) and Regional Forecast, 2020-2027,” the market was worth USD 5.91 billion in 2019 and will exhibit a CAGR of 6.7% during the forecast period, 2020-2027.

Request a Sample Copy of the Research Report

Coronary stents are small a metal mesh that that are mostly used in PCI (Percutaneous Coronary Intervention) procedures. These products are widely used in surgical procedures associated with the treatment of coronary heart diseases. They ability of coronary stents to stabilize surgical procedures and minimize the side effects associated with these surgeries will lead to a wider product adoption. Technological advancements in these products have helped improve surgical procedures and subsequently increase the success rate. The increasing adoption of coronary stents across the world will have a direct impact on the growth of the overall market in the coming years. In addition to these factors, the cost-effectivity of the product has contributed to the growing adoption. The presence of several health reimbursement policies will constitute an increase in the overall market size in the foreseeable future.

Increasing Number of Regulatory Approvals Will Provide Impetus to Market Growth

The report encompasses several factors that have contributed to the growth of the overall market in recent years. Among all factors, the increasing number of regulatory approvals by leading organizations such as the Food and Drug Administration (FDA) will have the highest impact on market growth. In May 2018, Abbott announced that it has received approval for Xience Sierra. The product is the newest generation of the company’s gold standard Xience everolimus-eluting coronary stent system. Abbott’s latest approval will not just benefit the company but will have a direct impact on the growth of the overall market in the coming years.

Quick Buy Coronary Stent Market

North America to Emerge Dominant; Increasing Prevalence of Heart Diseases to Aid Growth

The report analyses the ongoing market trends across five major regions, including North America, Latin America, Europe, Asia Pacific, and the Middle East and Africa. Among all regions, the market in North America is projected to emerge dominant in the coming years. The high prevalence of coronary heart diseases across the United States will aid the growth of the regional market. The presence of several large scale manufacturers will also contribute to market growth. The increasing investment in product R&D by major companies will emerge in favor of market growth. The increasing adoption of coronary stents in hospitals and surgical centers will create several opportunities for market growth. As of 2019, the market in North America was worth USD 2.35billion and this value is projected to increase further in the coming years. The market in Asia Pacific is expected to exhibit the highest CAGR in the coming years owing to the adoption of sedentary lifestyle habits.

List of companies profiled in the report:

  • Biotronik SE & Co. KG
  • Cook
  • C. R. Bard, Inc.
  • MicroPort Scientific Corporation
  • Terumo Corporation
  • B. Braun Melsungen AG
  • Abbott
  • Boston Scientific Corporation
  • Medtronic
  • Other players

Have Any Query? Ask Our Experts

An Overview of the Impact of COVID-19 on this Market:

The recent corona virus outbreak has had an adverse impact on several businesses across the world. Due to the severity of the disease, governments across the world are taking strict measures to curb the spread of the disease. Accounting to the rapid spread of the disease, several businesses have been shut down.

The report will include the impact of the Covid-19 pandemic on the global. It will also include the strategies that major companies are adopting to overcome the downfalls during this pandemic.

Click here to get the short-term and long-term impact of COVID-19 on this Market.

Please visit:

Industry Developments:

September 2018: BIOTRONIK, Inc., announced that it has received U.S.FDA approval for PK PAPYRUS Covered Coronary Stent System. This product is used to seal the perforation so as to stop the blood leakage during surgical procedure and avoid life-threatening complication.

About Us:

Fortune Business Insights™ offers expert corporate analysis and accurate data, helping organizations of all sizes make timely decisions. We tailor innovative solutions for our clients, assisting them address challenges distinct to their businesses. Our goal is to empower our clients with holistic market intelligence, giving a granular overview of the market they are operating in.

Our reports contain a unique mix of tangible insights and qualitative analysis to help companies achieve sustainable growth. Our team of experienced analysts and consultants use industry-leading research tools and techniques to compile comprehensive market studies, interspersed with relevant data.

At Fortune Business Insights™, we aim at highlighting the most lucrative growth opportunities for our clients. We therefore offer recommendations, making it easier for them to navigate through technological and market-related changes. Our consulting services are designed to help organizations identify hidden opportunities and understand prevailing competitive challenges.

Contact Us:

Fortune Business Insights™ Pvt. Ltd.

308, Supreme Headquarters,

Survey No. 36, Baner,

Pune-Bangalore Highway,

Pune – 411045, Maharashtra, India.


US:+1 424 253 0390

UK : +44 2071 939123

APAC : +91 744 740 1245

Email: [email protected]